[Association between glutamate receptor 2 polymorphisms and epilepsy in children]

Area of Science:

• Neurogenetics
• Molecular Biology
• Human Genetics

Context:

• Epilepsy (EP) is a significant neurological disorder with a complex genetic basis.
• Understanding the genetic factors contributing to EP susceptibility and drug resistance is crucial for effective treatment strategies.
• The glutamate receptor 2 (GRIK2) gene plays a role in neuronal function and has been implicated in various neurological conditions.

Purpose:

• To investigate the association between two single nucleotide polymorphisms (SNPs), rs9390754 and rs4840200, in the GRIK2 gene and genetic susceptibility to epilepsy (EP).
• To explore the potential role of these SNPs in the development of refractory epilepsy in a Han Chinese population.

Summary:

• A case-control study involving 284 EP children and 315 controls was conducted using PCR-RFLP to analyze genotypes of rs9390754 and rs4840200 in the GRIK2 gene.
• SNP rs9390754 genotype and allele frequencies significantly differed between EP and control groups (P=0.016 and P=0.002, respectively).
• The C allele of SNP rs4840200 was significantly more frequent in refractory EP cases compared to non-refractory cases (OR=1.435, P=0.037), suggesting a role in drug resistance.

Impact:

• The findings suggest that polymorphisms in the GRIK2 gene, particularly rs9390754, may contribute to epilepsy susceptibility in the Han population of Central China.
• The C allele of SNP rs4840200 may serve as a genetic marker for predicting drug resistance in pediatric epilepsy.
• This research provides valuable insights into the genetic underpinnings of epilepsy and drug resistance, potentially informing future diagnostic and therapeutic approaches.